Explore more publications!

Press Releases

Financial statements of the ECB for 2025

Financial statements of the ECB for 2025

Markus Heitkoetter’s Building Your Financial Fortress Becomes #1 Amazon Best Seller Across Multiple Categories
CYBERA Partners With Recorded Future to Deliver Money Mule Intelligence to Financial Institutions
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Runway Growth Finance Corp. Announces First Quarter 2026 Dividend of $0.33 per Share
TIFIN Give to Power Donor-Advised Fund Experience for Confluence Financial Partners
StepStone Group to Present at the RBC Capital Markets Global Financial Institutions Conference
Georgia Financial Educators Council Announces Selection of Ronke Adetoba Adeyemi to its Expert Advisory Board
Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2025
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
Where Food Comes From, Inc. Reports 2025 Financial Results
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
Inuvo to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on Thursday, March 5th at 4:15 P.M. ET
Almea plans to Establish an AI-Native Wealth Bank, Subject to Regulatory Approval— Pioneering Agent-Driven Finance Era
Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026
BeautyHealth to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions